Healthcare -
Biotechnology - NASDAQ - US
$ 41.1
1.61 %
$ 2.66 B
Market Cap
-17.56
P/E
KYMR - DEPRECIATION & AMORTIZATION
Depreciation & Amortization KYMR - Kymera Therapeutics, Inc.
3.56 M
LAST VALUE
21.95%
2 YEAR CAGR
77.04%
5 YEAR CAGR
0.00%
10 YEAR CAGR